Loading
Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares Consolidation therapy, Hypofractionated radiotherapy, PET/CT, PD-1 / PD-L1 immune checkpoint & T-cell activation and the tags subtype-page, lung.
Shares Martin Reck, Maintenance therapy, PD-1 / PD-L1 immune checkpoint & T-cell activation, Atezolizumab and the tags subtype-page, lung.
Shares PET/CT, PD-1 / PD-L1 immune checkpoint & T-cell activation, MRI, Atezolizumab and the tags subtype-page, lung.
Shares Brain metastases (intracranial disease), Stereotactic radiosurgery (Gamma Knife, CyberKnife, linac SRS), Daiichi Sankyo, Topoisomerase-I inhibitors (and ADC payloads) and the tags subtype-page, lung.
Shares Brain metastases (intracranial disease), Amgen, PD-1 / PD-L1 immune checkpoint & T-cell activation, Roche / Genentech and the tags subtype-page, lung.
Shares Whole-brain radiotherapy (WBRT), Brain metastases (intracranial disease), Stereotactic radiosurgery (Gamma Knife, CyberKnife, linac SRS), Roche / Genentech and the tags subtype-page, lung.
Shares Brain metastases (intracranial disease), Stereotactic radiosurgery (Gamma Knife, CyberKnife, linac SRS), Roche / Genentech, Carboplatin and the tags subtype-page, lung.
Shares Platinum + etoposide (EP / CE), Brain metastases (intracranial disease), Stereotactic radiosurgery (Gamma Knife, CyberKnife, linac SRS), Daiichi Sankyo and the tags subtype-page, lung.
The same record for scripts and assistants; checked 2026-09-17. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.